The Cooper Companies, Inc. (NASDAQ:COO) Stock Holdings Lifted by Geode Capital Management LLC

Geode Capital Management LLC raised its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 1.0% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 4,796,556 shares of the medical device company's stock after purchasing an additional 48,559 shares during the period. Geode Capital Management LLC owned 2.41% of Cooper Companies worth $527,476,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the stock. Barclays PLC grew its position in shares of Cooper Companies by 0.7% in the 3rd quarter. Barclays PLC now owns 462,947 shares of the medical device company's stock worth $51,082,000 after acquiring an additional 3,070 shares in the last quarter. Nomura Asset Management Co. Ltd. lifted its stake in Cooper Companies by 8.1% during the third quarter. Nomura Asset Management Co. Ltd. now owns 58,703 shares of the medical device company's stock worth $6,477,000 after purchasing an additional 4,408 shares during the last quarter. MML Investors Services LLC boosted its holdings in Cooper Companies by 1.6% in the third quarter. MML Investors Services LLC now owns 17,787 shares of the medical device company's stock worth $1,963,000 after purchasing an additional 280 shares during the period. iSAM Funds UK Ltd acquired a new stake in shares of Cooper Companies during the third quarter worth $501,000. Finally, Worldquant Millennium Advisors LLC lifted its position in shares of Cooper Companies by 1,701.1% in the 3rd quarter. Worldquant Millennium Advisors LLC now owns 76,854 shares of the medical device company's stock worth $8,480,000 after buying an additional 72,587 shares during the last quarter. Institutional investors own 24.39% of the company's stock.

Cooper Companies Price Performance

Shares of NASDAQ COO traded down $1.87 during mid-day trading on Friday, reaching $94.85. 1,779,826 shares of the company traded hands, compared to its average volume of 1,163,765. The Cooper Companies, Inc. has a fifty-two week low of $84.76 and a fifty-two week high of $112.38. The firm has a market cap of $18.93 billion, a PE ratio of 48.64, a price-to-earnings-growth ratio of 2.52 and a beta of 0.97. The stock has a fifty day simple moving average of $103.49 and a 200-day simple moving average of $98.87. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. During the same period in the previous year, the company earned $0.87 earnings per share. Cooper Companies's revenue was up 9.8% compared to the same quarter last year. Equities research analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CEO Albert G. White III sold 114,992 shares of the stock in a transaction on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total value of $12,710,065.76. Following the completion of the sale, the chief executive officer now owns 165,273 shares in the company, valued at $18,267,624.69. This represents a 41.03 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 2.00% of the stock is currently owned by insiders.

Analysts Set New Price Targets

COO has been the topic of a number of recent research reports. Robert W. Baird raised their target price on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an "outperform" rating in a report on Thursday, August 29th. Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a research report on Friday, December 6th. Piper Sandler upped their price objective on Cooper Companies from $115.00 to $120.00 and gave the stock an "overweight" rating in a research note on Thursday, August 29th. Citigroup cut their target price on Cooper Companies from $116.00 to $115.00 and set a "buy" rating on the stock in a research note on Friday, December 6th. Finally, StockNews.com lowered shares of Cooper Companies from a "buy" rating to a "hold" rating in a research report on Wednesday. Four research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, Cooper Companies has an average rating of "Moderate Buy" and a consensus price target of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.